Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2Cl.Mn.4H2O |
Molecular Weight | 197.905 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.O.[Cl-].[Cl-].[Mn++]
InChI
InChIKey=CNFDGXZLMLFIJV-UHFFFAOYSA-L
InChI=1S/2ClH.Mn.4H2O/h2*1H;;4*1H2/q;;+2;;;;/p-2
DescriptionSources: https://www.alfa.com/en/catalog/032808/https://www.ncbi.nlm.nih.gov/pubmed/6658791https://www.ncbi.nlm.nih.gov/pubmed/3725729 | https://www.ncbi.nlm.nih.gov/pubmed/3989083 | https://www.ncbi.nlm.nih.gov/pubmed/25464291 | https://www.ncbi.nlm.nih.gov/pubmed/20934746https://google.com/patents/CN104529454A?http://pubs.acs.org/doi/pdfplus/10.1021/jo970656jhttps://www.drugs.com/pro/manganese-sulfate-injection.htmlhttp://www.druginfosys.com/drug.aspx?drugcode=2295&type=1https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=184 | https://www.ncbi.nlm.nih.gov/pubmed/24861367Curator's Comment: description was created based on several sources, including
https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ucm260883.htm
Sources: https://www.alfa.com/en/catalog/032808/https://www.ncbi.nlm.nih.gov/pubmed/6658791https://www.ncbi.nlm.nih.gov/pubmed/3725729 | https://www.ncbi.nlm.nih.gov/pubmed/3989083 | https://www.ncbi.nlm.nih.gov/pubmed/25464291 | https://www.ncbi.nlm.nih.gov/pubmed/20934746https://google.com/patents/CN104529454A?http://pubs.acs.org/doi/pdfplus/10.1021/jo970656jhttps://www.drugs.com/pro/manganese-sulfate-injection.htmlhttp://www.druginfosys.com/drug.aspx?drugcode=2295&type=1https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=184 | https://www.ncbi.nlm.nih.gov/pubmed/24861367
Curator's Comment: description was created based on several sources, including
https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ucm260883.htm
Manganese citrate is generally recognized as safe direct food additive. Manganese citrate complex has being used in the determination of liver enzyme activities in the aging process and following treatment with aminoethylisothiuronium bromide hydrobromide (AET).
Originator
Sources: https://www.americanelements.com/manganese-ii-iodide-7790-33-2https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19610920&CC=GB&NR=877677A&KC=Ahttp://www.newworldencyclopedia.org/entry/Manganese
Curator's Comment: Manganese was first discovered by Torbern Olof Bergman in 1770 and first isolated by Johann Gottlieb Gahn in 1774.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1075097 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19032027 |
|||
Target ID: CHEMBL1795148 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25974698 |
|||
Target ID: CHEMBL4612 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25974698 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseManganese is used for prevention and treatment of manganese deficiency, a condition in which the body doesn’t have enough manganese. |
|||
Primary | Unknown Approved UseManganese is used for weak bones (osteoporosis). |
|||
Palliative | Unknown Approved UseEarly research suggests that taking manganese along with calcium helps improve symptoms of PMS, including pain, crying, loneliness, anxiety, restlessness, irritability, mood swings, depression, and tension. |
|||
Curative | MANGANESE SULFATE Approved UseManganese Sulfate Injection, USP is indicated for use as a supplement to intravenous solutions given for Total Parenteral Nutrition (TPN). Administration helps to maintain plasma levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. |
|||
Primary | MANGANESE SULFATE Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Cytochrome oxidase determination using a manganese citrate complex. | 1970 |
|
Transformation of BALB/c-3T3 cells: IV. Rank-ordered potency of 24 chemical responses detected in a sensitive new assay procedure. | 1993 Jul |
|
Manganese: brain transport and emerging research needs. | 2000 Jun |
|
Equilibrium and kinetics studies of reactions of manganese acetate, cobalt acetate, and bromide salts in acetic acid solutions. | 2001 Jun 18 |
|
Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. | 2005 Mar |
|
Persistent alterations in biomarkers of oxidative stress resulting from combined in utero and neonatal manganese inhalation. | 2005 May |
|
Chronic exposure to manganese sulfate leads to adverse dose-dependent effects on the neurobehavioral ability of rats. | 2016 Nov |
|
Yolk-Shell MnO@ZnMn(2) O(4) /N-C Nanorods Derived from α-MnO(2) /ZIF-8 as Anode Materials for Lithium Ion Batteries. | 2016 Oct |
|
Top-Down Strategy to Synthesize Mesoporous Dual Carbon Armored MnO Nanoparticles for Lithium-Ion Battery Anodes. | 2017 Apr 12 |
Patents
Sample Use Guides
In Vitro Use Guide
Curator's Comment: In vitro cytotoxicity of manganese oxide (MnO) using live/dead cell assay, lactate dehydrogenase assay, and reactive oxygen species detection with variation of the concentration of nanoparticles (5-500 ug/ml), incubation time (18-96 h), and different human cell lines (lung adenocarcinoma, breast cancer cells, and glioblastoma cells) was studied. The cytotoxic effect was negligible for 18 h incubation even at highest concentration of 500 ug/ml MnO nanoparticle.
Unknown
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
342911
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
||
|
CFR |
21 CFR 184.1446
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
||
|
NCI_THESAURUS |
C29730
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
QQE170PANO
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
m7063
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | Merck Index | ||
|
13446-34-9
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
SUB27073
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
C61823
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
DBSALT001361
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
100000090497
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
1375127
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
26003
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
86368
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
C025340
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
29261
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID00858866
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
CHEMBL1200693
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
SUB14468MIG
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
MANGANESE(II) CHLORIDE
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
QQE170PANO
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
63041
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY | |||
|
4521
Created by
admin on Fri Dec 15 15:49:22 GMT 2023 , Edited by admin on Fri Dec 15 15:49:22 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD